In CACS mice, the pretreatment of SNAP in the BLA ameliorated IBS-like symptoms, increased the expression of occludin and ZO1 and reduced the expression of inflammatory factors, which suggested that MCHR1 was involved in stress-inducing intestinal symptoms. This evidence concerns the gene MCHR1 and irritable bowel syndrome.